Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors.
Cancers (Basel). 2024 Apr 10;16(8):1456. doi: 10.3390/cancers16081456.
Cancers (Basel). 2024.
PMID: 38672538
Free PMC article.
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis.
Smoots SG, Schreiber AR, Jackson MM, Bagby SM, Dominguez ATA, Dus ED, Binns CA, MacBeth M, Whitty PA, Diamond JR, Pitts TM.
Smoots SG, et al. Among authors: dus ed.
Breast Cancer Res. 2024 Mar 1;26(1):35. doi: 10.1186/s13058-024-01799-5.
Breast Cancer Res. 2024.
PMID: 38429789
Free PMC article.
Item in Clipboard
Cite
Cite